Using a conditional transgenic HER2/neu-induced mouse model of breast cancer, Pitteri et al. [21] detected proteins that originated from the microenvironment in plasma, demonstrating that the plasma proteome is a sensitive biomonitor of tumor-host interactions. Here, ERBB2 is linked to breast carcinoma.